RMC No. 79-2025: NRDSP VAT Return Filing and Payment Deadline Extended to August 5, 2025

NRDSPs get until August 5, 2025 to file Q2 2025 VAT returns and pay VAT due under RMC No. 79-2025 during the VDS Portal transition. Nonresident Digital Service Providers with Value-Added Tax obligations for the second quarter of 2025 have until August 5, 2025 to file their VAT returns and pay the corresponding VAT due. […]

RMC No. 71-2025: Revised VAT Zero-Rating Certificate Formats for IPAs, Registered Export Enterprises, and High-Value Domestic Market Enterprises

RMC No. 71-2025 requires IPAs to immediately use revised VAT zero-rating certificate formats for RBEs under CREATE MORE and pre-CREATE incentives. Investment Promotion Agencies must use the revised VAT Zero-Rating Certificate formats immediately for certificates issued to Registered Business Enterprises. From July 11, 2025 onward, VAT zero-rating certificates issued by IPAs must conform to the […]

RMC No. 62-2025: Updated VAT-Exempt Medicines List for Cancer, Diabetes, Hypertension, High Cholesterol, Mental Illnesses, and Tuberculosis

RMC No. 62-2025 updates VAT-exempt medicines for key diseases, requiring pharmacies and healthcare sellers to verify FDA publication and product tax codes. Pharmacies, hospitals, clinics, distributors, importers, and VAT-registered sellers of covered medicines must immediately check the latest FDA-published VAT-exempt medicines list before issuing invoices, pricing products, or claiming VAT treatment. RMC No. 62-2025 confirms […]

RMC No. 52-2025: New VAT Return Form for Nonresident Digital Service Providers in the Philippines

RMC No. 52-2025 makes BIR Form 2550-DS available for VAT returns of nonresident digital service providers under RA 12023 and RR 3-2025. Nonresident digital service providers now have a dedicated VAT return: BIR Form No. 2550-DS, formally identified as the Value-Added Tax Return for Nonresident Digital Service Providers, January 2025 version. This matters immediately for […]

RMC No. 25-2025: FDA Updates to VAT-Exempt Medicines for Diabetes, Hypertension, High Cholesterol, and Mental Illness

RMC No. 25-2025 confirms FDA updates to VAT-exempt medicines for diabetes, hypertension, high cholesterol, and mental illness under TRAIN and CREATE. Businesses selling, purchasing, distributing, or accounting for medicines covered by the FDAโ€™s updated VAT-exempt list must immediately review their product master files, invoicing settings, and VAT treatment because the VAT exemption takes effect upon […]

RMC No. 131-2024: Updated VAT-Exempt Medicine List for Cancer, Diabetes, and Mental Illness Products

RMC No. 131-2024 updates the VAT-exempt medicine list for cancer, diabetes, and mental illness products, with effectivity tied to FDA publication. Businesses selling, dispensing, importing, distributing, or accounting for qualified medicines must immediately check the latest FDA-published list of VAT-exempt medicines because the VAT exemption under the CREATE Act takes effect based on the FDAโ€™s […]

RMC No. 34-2024: FDA Updates to VAT-Exempt Medicines for Cancer, Hypertension, and Mental Illness Under TRAIN and CREATE

RMC No. 34-2024 confirms FDA updates to VAT-exempt medicines for cancer, hypertension, and mental illness, with effect from FDA publication. Businesses selling medicines for cancer, hypertension, and mental illness must immediately check the latest Food and Drug Administration updates to the VAT-exempt product list because VAT exemption takes effect on the date the FDA publishes […]

RMC No. 17-2024: Updated VAT-Exempt Medicines List for Cancer, Diabetes, Hypertension, Kidney Disease, Mental Illness, and Tuberculosis

RMC No. 17-2024 updates VAT-exempt medicines for key diseases, including inclusions and a hypertension medicine deletion tied to FDA publication. Pharmaceutical companies, drugstores, hospitals, clinics, and VAT-registered sellers of medicines must immediately verify whether the medicines they sell are affected by the latest FDA-endorsed updates to the VAT-exempt medicines list. RMC No. 17-2024 publishes the […]

RMC No. 7-2024: VAT Exemption Ends for COVID-19 PPE, Drugs, Vaccines, and Medical Devices

RMC No. 7-2024 ends the VAT exemption for covered COVID-19 PPE, drugs, vaccines, and medical devices starting January 1, 2024. Businesses selling or importing COVID-19-related personal protective equipment, drugs, vaccines, and medical devices must treat the covered transactions as subject to value-added tax starting January 1, 2024. RMC No. 7-2024 confirms that the temporary VAT […]